Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) trial

Ocular Immunology and Inflammation

Volumn 20, Issue 2, 2012, Pages 104-112

  Sen, H Nida ^a   Drye, Lea T ^b   Goldstein, Debra A ^c   Larson, Theresa A ^a   Merrill, Pauline T ^d   Pavan, Peter R ^e   Sheppard, John D ^f,g   Burke, Alyce ^b   Srivastava, Sunil K ^h   Jabs, Douglas A ^b,i  

^a NATIONAL EYE INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f Virginia Eye Consultants ^*  (United States)

^g Thomas R Lee Center for Ocular Pharmacology   (United States)

^h EMORY EYE CENTER   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Hypotony; Multicenter uveitis steroid treatment trial; Uveitis; Visual impairment; Visual loss

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; APHAKIA; ARTICLE; CATARACT EXTRACTION; CAUCASIAN; DISEASE DURATION; FEMALE; HISPANIC; HUMAN; INTRAOCULAR HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PSEUDOPHAKIA; STEROID THERAPY; UVEITIS; VISUAL IMPAIRMENT; VITRECTOMY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANIMALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; OCULAR HYPOTENSION; PREVALENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 84858238017     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.647228     Document Type: Article

References (30)

1. Pederson JE., Hypotony. In Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia, PA: Lippincott-Raven; 1999:1-8.
2. Schubert HD. Postsurgical hypotony: relationship to fstuli-zation, infammation, chorioretinal lesions and the vitreous. Surv Ophthalmol. 1996;41(2):97-125. (Pubitemid 26322505)
3. Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. 1987;28(3):477-481. (Pubitemid 17040855)
4. Tran VT, Mermoud A, Herbort CP. Appraisal and management of ocular hypotony and glaucoma associated with uveitis. Int Ophthalmol Clin. 2000:40(2):175-203. (Pubitemid 30235949)
5. Kim HC, Hayashi A, Shalash A, de Juan E Jr. A model of chronic hypotony in the rabbit. Graefes Arch Clin Exp Ophthalmol. 1998;236(1):69-74. (Pubitemid 28080574)
6. Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol. 2010;150(4):534-542.
7. Tugal-Tutkun I, Havrlikova K, Power WJ, et al. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103(3):375-383. (Pubitemid 26085891)
8. Kump LI, Castañeda RA, Androudi SN, et al. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology. 2006;113(10):1874-1877. (Pubitemid 44442436)
9. Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idio-pathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840-846.
10. Kaçmaz RO, Kempen JH, Newcomb C, et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular infammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828-836.
11. Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116(8):1544-1551.
12. O'Connell SR, Majji AB, Humayun MS, et al. The surgical management of hypotony. Ophthalmology. 2000;107(2):318-323. (Pubitemid 30191412)
13. Jonas JB, Vossmerbaeumer U, Kamppeter BA. Chronic prephthisical ocular hypotony treated by intravit-real triamcinolone acetonide. Acta Ophthalmol Scand. 2004;82(5):637. (Pubitemid 39386991)
14. Ugahary LC, Ganteris E, Veckeneer M, et al. Topical ibo-pamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. Am J Ophthalmol. 2006;141(3):571-573. (Pubitemid 43265971)
15. Friedman SM, Mahootchi A. The use of intravitreal gas for the treatment of ocular hypotony after glaucoma fltration surgery. Ophthalmic Surg Lasers Imaging. 2006;37(3):234-235. (Pubitemid 43886119)
16. Kapur R, Birnbaum AD, Goldstein DA, et al. Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina. 2010;30(1):140-145.
17. Kucukerdonmez C, Beutel J, Bartz-Schmidt KU, et al. Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol. 2009;93(2):235-239.
18. Tosi GM, Schiff W, Barile G, et al. Management of severe hypotony with intravitreal injection of viscoelastic. Am J Ophthalmol. 2005;140(5):952-954. (Pubitemid 41727708)
19. Gupta P, Gupta A, Gupta V, et al. Successful outcome of pars plana vitreous surgery in chronic hypotony due to uveitis. Retina. 2009;29(5):638-643.
20. Yu EN, Paredes I, Foster CS. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Infamm. 2007;15(1):11-17. (Pubitemid 46328437)
21. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, et al. The Multicenter Uveitis Steroid Treatment Trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010; 149(4):550-561.
22. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516. (Pubitemid 41224845)
23. Klein R, Klein BE, Moss SE, et al. Inter-observer variation in refraction and visual acuity measurement using a standardized protocol. Ophthalmology. 1983;90(11):1357-1359. (Pubitemid 14200820)
24. Tugal-Tutkun I, Aydin-Akova Y, Güney-Tefekli E, et al. Referral patterns, demographic and clinical features, and visual prognosis of Turkish patients with sarcoid uveitis. Ocul Immunol Infamm. 2007;15(4):337-343. (Pubitemid 47347033)
25. Khalatbari D, Stinnett S, McCallum RM, Jaffe GJ. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology. 2004;111(2):357-362. (Pubitemid 38183245)
26. Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol. 2008; 145(3):472-479. (Pubitemid 351240889)
27. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001 May;131(5):599-606. (Pubitemid 32422116)
28. Thomas, KW, Hunninghake, GW. Sarcoidosis. JAMA. 2003;289(24):3300-3303. (Pubitemid 37430085)
29. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224-1234. (Pubitemid 27183653)
30. Lindsey JD, Weinreb RN. Effects of prostaglandins on uveo-scleral outfow. In Alm A, Weinreb RN, eds. Uveoscleral Outfow. London, England: Mosby-Wolfe; 1998: 41-55.